Gut microbiota and probiotics in chronic liver diseases.
about
Intestinal permeability defects: is it time to treat?Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of MetabolomicsPromising Therapy Candidates for Liver FibrosisOxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-AcetylcysteineInflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosisGut microbiota in alcoholic liver disease: pathogenetic role and therapeutic perspectivesLeaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitisSystemic effects of gut microbiota and its relationship with disease and modulationInflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features.Inhibition of nitric oxide production reverses diabetes-induced Kupffer cell activation and Klebsiella pneumonia liver translocationEfficiency of double layered microencapsulated probiotic to modulate proinflammatory molecular markers for the management of alcoholic liver disease.Protective effect of aplysin on liver tissue and the gut microbiota in alcohol-fed rats.Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis.Gut microbiota-related complications in cirrhosisGut microbiota-based translational biomarkers to prevent metabolic syndrome via nutritional modulationUrine metabolic profile changes of CCl4-liver fibrosis in rats and intervention effects of Yi Guan Jian Decoction using metabonomic approach.The Gordian Knot of dysbiosis, obesity and NAFLD.What does irritable bowel syndrome share with non-alcoholic fatty liver disease?The gut microbiota and the liver: implications for clinical practice.Oral administration of Saccharomyces boulardii ameliorates carbon tetrachloride-induced liver fibrosis in rats via reducing intestinal permeability and modulating gut microbial composition.Commensal microbiota is hepatoprotective and prevents liver fibrosis in miceGut microbiota modulate the immune effect against hepatitis B virus infection.Role of intestinal microbiota and metabolites on gut homeostasis and human diseases.SIV-induced Translocation of Bacterial Products in the Liver Mobilizes Myeloid Dendritic and Natural Killer Cells Associated With Liver DamageGut microbiome alterations in patients with stage 4 hepatitis C.Probiotics and Nonalcoholic Fatty liver Disease.Bench-to-beside review: acute-on-chronic liver failure - linking the gut, liver and systemic circulation.The intestine and the kidneys: a bad marriage can be hazardous.The gut microbiome and liver cancer: mechanisms and clinical translation.Probiotic as a novel treatment strategy against liver diseaseBifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota.NMR-based urinary profiling of lactulose/mannitol ratio used to assess the altered intestinal permeability in acute on chronic liver failure (ACLF) patients.Probiotics promote rapid-turnover protein production by restoring gut flora in patients with alcoholic liver cirrhosis.Elevated serum soluble CD14 levels in chronic HBV infection are significantly associated with HBV-related hepatocellular carcinoma.Regulation of T helper 17 by bacteria: an approach for the treatment of hepatocellular carcinoma.Symbiotic formulation in experimentally induced liver fibrosis in rats: intestinal microbiota as a key point to treat liver damage?Persistent abnormal liver fibrosis after weaning off parenteral nutrition in pediatric intestinal failure.Treatment efficacy of a probiotic preparation for non-alcoholic steatohepatitis: a pilot trial.Microbiota, NASH, HCC and the potential role of probiotics.Fecal microbiota transplantation prevents hepatic encephalopathy in rats with carbon tetrachloride-induced acute hepatic dysfunction.
P2860
Q24629228-AD52A453-8080-44B4-A50A-9E38B89CBF28Q26753047-B21F18E8-F74F-4455-936C-988BBC9E4B13Q26766727-0F64EF89-F932-4196-BB9E-D8CC2DB9F059Q26773384-18436A37-070F-4CA5-A3EE-1D2BD18B5356Q26778000-6D874228-D3CA-4770-A170-56B4E78CA349Q26864127-271E5996-26FC-4B37-AFC9-B5754110C17CQ26991664-7F976DCE-C77C-4158-BAE2-375E09789890Q28083900-A588E0F3-539E-4FA1-990A-3FFD01BF19FCQ30234950-3E68A15D-1240-40A4-B2B9-C49EB220C168Q33663789-E1BEDB7B-A8DE-4FB9-A55D-8048E28CC7FFQ33748252-5149D293-8E9F-4B84-8BB6-A2F51F0D3AC8Q33807041-CBC97C9E-D161-4806-8C46-89E00EF39589Q34479345-2B5061A5-F220-4783-B39D-E4656CB0D048Q34499061-7B3AD218-A4F2-41AB-BC12-F89931C3E8E2Q34669782-8DA58582-40A0-4036-9E62-F6FC71ED81D7Q34750733-4773FE17-FA46-4C89-A39E-31C97C883AB5Q34956813-370DEE62-8CA9-46A3-AD1D-FF8BFE819256Q34983471-A426F745-C927-4A61-ADE1-78A9F0C18382Q35019661-B84B8E37-5BAC-4859-ADC4-BB5BFD4A8DDFQ35256601-B56FE5E5-AAA4-4730-AA11-7E7DDC3C2268Q35481673-5306BD72-C458-4BA7-B82A-83CD2F7916A0Q35745517-A0662368-819C-416C-A81C-CF4583AFECFEQ36243299-592AED6E-2D9D-448A-888D-6851771167E1Q36440241-95276375-A81E-4794-8E61-E35D89BB276CQ37251311-88C2EFB3-A668-44BF-B8A5-E4CCBEC17343Q37708418-BD0A479E-BF6D-4C15-AABB-4F87CC4E1C2EQ37959188-32AC6211-1DAA-4D9C-8899-3A020F4818DDQ38393212-39E5509A-365D-4792-87E9-601E8530F813Q39414187-A5A79182-9753-4FE4-AD88-70EA54B0D25FQ39974040-91ADCB85-6FDB-4CB0-9C4B-C080528984A1Q40087509-C1233D59-1B9F-4882-A1E2-7774DF14988BQ40541675-DA5B3D8B-5D6F-4994-B61E-EF032C7AE3E7Q40707112-88EE9977-1A7A-4996-993F-CC9B07DCB423Q40880190-FDA2D9B2-F152-49A5-9EBE-37DD848FE424Q42004790-42FE4799-EE44-4887-9108-522AE6568B3EQ42434928-9F38A760-2DB2-4E94-8C8E-93989C7C430FQ45169013-B7A8D547-8600-4025-85AE-76BDB88AB26EQ46259732-C7995A6B-59F9-494A-BBA5-F42FEC2EFC54Q46380108-9387FA85-2223-42B9-B91B-B2771CB54C8EQ47162191-0E7AE0C9-AC76-4E86-ABB7-25E2AA415F78
P2860
Gut microbiota and probiotics in chronic liver diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Gut microbiota and probiotics in chronic liver diseases.
@en
Gut microbiota and probiotics in chronic liver diseases.
@nl
type
label
Gut microbiota and probiotics in chronic liver diseases.
@en
Gut microbiota and probiotics in chronic liver diseases.
@nl
prefLabel
Gut microbiota and probiotics in chronic liver diseases.
@en
Gut microbiota and probiotics in chronic liver diseases.
@nl
P2093
P1476
Gut microbiota and probiotics in chronic liver diseases.
@en
P2093
Angelo Tiso
Anna Del Prete
Camillo Del Vecchio Blanco
Carmelina Loguercio
Claudia Cesaro
Concetta Tuccillo
Gaetano Cotticelli
Rita Cariello
P304
P356
10.1016/J.DLD.2010.10.015
P577
2010-12-16T00:00:00Z